-
Signature
-
/s/ Christopher Krueger, as Attorney-in-Fact
-
Stock symbol
-
VTYX
-
Transactions as of
-
May 31, 2023
-
Transactions value $
-
-$362,029
-
Form type
-
4
-
Date filed
-
6/1/2023, 05:53 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
VTYX |
Common Stock |
Options Exercise |
$2.13K |
+10.6K |
+21.97% |
$0.20* |
59K |
May 31, 2023 |
Direct |
|
transaction |
VTYX |
Common Stock |
Sale |
-$364K |
-10.6K |
-18.01% |
$34.26 |
48.4K |
May 31, 2023 |
Direct |
F1, F2 |
holding |
VTYX |
Common Stock |
|
|
|
|
|
34.7K |
May 31, 2023 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
VTYX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-10.6K |
-49.62% |
$0.00 |
10.8K |
May 31, 2023 |
Common Stock |
10.6K |
$0.20 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Chief Medical Officer